What NEMO Lab does

NEMO Lab S.R.L. is an Italian technology hub, founded around 2019-2020, that designs and develops high-tech innovation projects applied to neuromuscular diseases such as ALS (SLA), SMA, and muscular dystrophies. The company operates approximately 1,500 square meters of laboratory space inside ASST Grande Ospedale Metropolitano Niguarda in Milan, structured as ten specialized labs covering orthoses and 3D printing (Ortho Lab, 3D Printing Lab), assistive robotics (Biorobotic Lab), voice and message banking (Voice Lab), movement analysis (Me-Mo Lab), augmentative and alternative communication via eye-tracking and brain-computer interfaces (AAC/Opto Lab), home accessibility and domotics (Home Lab), VR-based rehabilitation (Entertainment Lab), and IoT-enabled telemonitoring (Smart Health Innovation Lab).

The company's most technologically advanced commercial products are the NIA (Nemo Intelligence Assistant) telemonitoring platform — a modular system comprising a wearable device for vital sign capture, a CE Class I certified web portal, HL7-FHIR interoperability, and a Level 3 AI engine for clinical decision support — and the AIlay4Care platform, an integrated cloud-based 'Digital Ally' that combines VR rehabilitation, AI-driven health prediction, web-based diagnostic apps, and Generative AI-driven 3D-printed customized orthotics. Proprietary AI capabilities span vocal marker detection (with CAMELOT Biomedical Systems), predictive analytics on PROMs data, computer vision for movement analysis, and AI-assisted materials design.

NEMO Lab's business model is a mix of sponsored R&D and technology-transfer services for medtech companies (Sharebot, CAMELOT, SolidColor, Dico Technologies, Ortopedia Castagna), consulting and training services for healthcare providers and homecare operators (notably VIVISOL), collaborative research funded by EU and regional grants (most recently the PR MARCHE FESR 2021-2027 AIlay4Care project with a EUR 1.36M EU contribution), and direct clinical services (voice banking, home adaptation, mobility vehicle consulting, telemonitoring pilots) delivered at its Niguarda facility. The company is governed by a Board of Directors under Director General Stefano Regondi, with Emanuele Frontoni as Scientific Director and Luca Maria Munari as Health Director, and is institutionally tied to Fondazione Serena Onlus and the NeMO Clinical Centers network.

Name

NEMO Lab

Legal name

NEMO LAB S.R.L.

Website

https://nemolab.it

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

NEMO Lab is an Italian technology hub that develops and applies AI, robotics, 3D printing, VR, and telemonitoring solutions to improve care for patients with neuromuscular diseases, operating specialized labs inside ASST Niguarda hospital in Milan.

Ownership category

akta.pro rank

Product category

Assistive Healthcare Technology

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Neurorehabilitation Centers (HLAFAFAH)

akta.pro secondary industries

Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK), At-Home Lab Testing & Diagnostics-Integrated Virtual Care (HLALAAAE)

Keywords

• Assistive healthcare technology
• Neuromuscular disease research
• Telemonitoring healthcare
• 3D printed orthotics
• Rehabilitation technology

Headquarters

HQ city

Milano

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. R&D Project Services: Sponsored research agreements with specialized companies, technology transfer projects, and R&D collaboration on neuromuscular disease technologies. Revenue generated through funded research projects and technology co-development.
2. Consulting Services: Specialized training courses on technology application in disease management and consulting for companies investing in healthcare. Direct service provision for home adaptation, mobility vehicle assessment, and voice banking.
3. EU/Regional Research Funding: Collaborative industrial research and experimental development projects funded by regional and EU programs. AILAY4Care project budget of 1,889,891.57 EUR with 1,359,211.37 EUR contributed by PR MARCHE FESR 2021-2027.
4. Intellectual Property Licensing: Protection and licensing of research patents developed in partnership with universities and research institutes.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

NEMO Lab is an Italian technology hub that designs and develops high-tech innovation projects applied to neuromuscular diseases. Operating through nine specialized laboratories (3D Printing, Biorobotic, Ortho, Home, Mobility, Me-Mo, Entertainment, AAC/Opto, Voice, and Smart Health Innovation), it delivers R&D services, digital health platforms, assistive devices, and direct patient services such as voice banking, smart-home adaptation, and vehicle accessibility assessments.

Product overview

NEMO Lab is a technology hub comprising nine specialized high-tech research laboratories dedicated to developing innovative technology projects applied to neuromuscular diseases. The portfolio spans a modular suite of services organized across: Ortho Lab and 3D Printing Lab (custom orthoses via additive manufacturing), Biorobotic Lab (assistive robotics), Voice Lab (voice/message banking and AAC), Me-Mo Lab (movement and posture analysis), AAC/Opto Lab (eye-tracking and brain-computer interface communication), Home Lab (smart home accessibility), Entertainment Lab (VR-based rehabilitation), and Smart Health Innovation Lab (IoT telemonitoring). The two most technologically advanced products are the NIA telemonitoring platform (wearable + AI analytics + cloud portal) and the AIlay4Care integrated digital platform (VR rehabilitation + web app + Generative AI + 3D printing). Technology transfer strategies include sponsored research agreements, IP licensing, joint laboratories, and high-tech startup contributions.

Differentiator

Problem solved

Functional benefit

Brands

• Ortho Lab: Laboratory focused on increasing the offer of orthoses and adaptive technologies for function, quality, comfort, aesthetic impact, hygienic management, cost and accessibility improvement.
• Mobility Lab
• Biorobotic Lab
• Voice Lab
• Me-Mo Lab
• AAC/Opto Lab
• Home Lab
• Entertainment Lab
• Smart Health Innovation Lab
• 3D Printing Lab

Products and services

• NIA (Nemo Intelligence Assistant)
• AIlay4Care Platform
• Voice and Message Banking Service
• Custom 3D Printed Orthoses
• Mobility Vehicle Adaptation Service
• Smart Home Adaptation Service
• Movement Analysis (Me-Mo Lab)
• VR-Based Rehabilitation (Entertainment Lab)

Quantifiable outcome

• NIA telemonitoring system operational in Rome and Brescia pilot programs to reduce unnecessary clinical visits
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature5 records

Partnerships

15 partnerships are on record, tiered core and minor.

• NET MEDICA ITALIA S.r.l.coreStrategic or Co-development Partner · 5 November 2024Partner in AILAY4Care project for developing integrated digital systems for neuromuscular and neurodegenerative disease treatment. Combined with NLAB Research Center, DEEP REALITY, and AIDAPT.
• DEEP REALITY S.r.l.coreTechnology or Integration · 5 November 2024Partner in AILAY4Care project contributing VR rehabilitation technology for the integrated platform development.
• AIDAPT S.r.l.coreTechnology or Integration · 5 November 2024Partner in AILAY4Care project for collaborative development of digital health solutions.
• Olmedo Vehicles S.p.A.minorStrategic or Co-development Partner · 14 October 2022Collaboration for vehicle adaptation consulting for people with disabilities. Olmedo, a leader in disability vehicle transport with a dedicated Mobility Division, provides expertise for vehicle modification assessments.
• CAMELOT Biomedical Systems S.r.l.coreTechnology or Integration · 19 September 2022Collaboration on AI algorithms and vocal markers research for neuromuscular disease monitoring. Development of software for identifying vocal markers correlated with specific diseases and detecting predictive trends using machine learning techniques.
• Politecnico di MilanocoreStrategic or Co-development Partner · 9 September 2022Academic partnership with Prof.ssa Serena Graziosi's research group for 3D printing materials research, including TPMS structure printing and characterization studies published in Additive Manufacturing journal.
• Dico Technologies S.r.l.coreTechnology or Integration · 29 April 2022R&D collaboration for testing and evaluating DICo 1000 device for Augmentative and Alternative Communication (AAC). The device enables communication for people unable to vocalize, particularly in intensive care settings.
• VIVISOLcoreStrategic or Co-development Partner · 7 March 2022Strategic collaboration to promote care models and appropriate technologies for effective home care continuity for neuromuscular disease patients after hospital discharge. VIVISOL, a leading European homecare company serving over 500,000 patients daily, brings expertise in managing healthcare and technological needs at patients' homes, including home oxygen therapy, mechanical ventilation, telemedicine, and assistive devices. NEMO Lab provides technological innovation capabilities and R&D expertise.
• SharebotcoreTechnology or Integration · 6 March 2022Partnership for prototyping customized solutions and developing new functional 3D-printed materials for neuromuscular and neurodegenerative diseases. Sharebot provides high-precision 3D printing technology expertise while NEMO Lab brings biomedical application knowledge for orthotic device development.
• RiAtlascoreTechnology or Integration · 26 October 2021Technical partner for NIA telemonitoring system development. RiAtlas is a spin-off of the University of Salerno providing telemedicine technology solutions.
• ZCube (Zambon Research Venture)minorStrategic or Co-development Partner · 23 October 2020Open Accelerator program participation for Smart Health Innovation Lab. ZCube accelerates digital health startups with funding opportunities up to EUR 100,000.
• IPCB-CNR (Istituto per i polimeri, composti e biomateriali del Consiglio Nazionale delle Ricerche)coreStrategic or Co-development Partner · 16 July 2020Institutional partnership for research, development, and technology transfer in innovative polymer materials and advanced manufacturing processes. Focus on Future Emerging Technologies in Advanced Materials for nanomedicine and health applications.
• Ortopedia CastagnacoreStrategic or Co-development Partner · 22 June 2020Four-year agreement dedicated to Ortho Lab for developing orthotic solutions. Ortopedia Castagna, established in 1947, specializes in restoring patient autonomy and independence through orthopedic devices.
• Cluster Lombardo Scienze della vitaminorStrategic or Co-development Partner · 15 June 2020Regional life sciences cluster partnership for developing innovative solutions for patients through competency integration.
• Fondazione Serena Onlus (Centro NEMO Italia)coreStrategic or Co-development Partner · 15 June 2020Parent organization and clinical partner providing NeMO Clinical Centers for patient care and research collaboration. NEMO Lab was established in the tradition of multidisciplinary care for ALS, SMA, and muscular dystrophy patients.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Ekso Bionics: Develops robotic exoskeletons (EksoNR, EksoUE) for rehabilitation and gait assistance in neurological conditions including stroke, MS, and spinal cord injury. Directly comparable to NEMO Lab's Biorobotic Lab and Mobility Lab given shared focus on powered orthoses and gait/standing restoration for neuromuscular populations.
• ReWalk Robotics: Developer of exoskeleton systems (ReWalk Personal 6.0 and ReStore) for individuals with spinal cord injuries and stroke survivors. Direct peer to NEMO Lab's Biorobotic and Mobility Labs because both target lower-limb mobility restoration through robotic exoskeletons for neurological and neuromuscular conditions.
• XRHealth: Operates VR-based telerehabilitation clinics reimbursed by payers for neurological and orthopedic conditions, pairing immersive experiences with remote clinician oversight. Direct peer to NEMO Lab's Entertainment Lab given parallel use of VR/AR for patient rehabilitation in hospital and home settings.
• PRC-Saltillo: Manufacturer of AAC devices and speech-generating devices (e.g., Accent, NovaChat, ChatPlus) widely used by individuals with motor neuron disease. Directly comparable to NEMO Lab's AAC/Opto Lab given overlapping product category of communication aids for patients who lose verbal ability.
• Tobii Dynavox: Global leader in eye-tracking-based augmentative and alternative communication (AAC) devices for individuals with communication impairments including ALS. Direct peer to NEMO Lab's AAC/Opto Lab given shared focus on eye-tracker and BCI-driven communication solutions for neuromuscular patients with speech loss.
• Myomo: Commercializes myoelectric arm braces (MyoPro) that restore arm and hand function for patients with neuromuscular weakness from stroke, ALS, and similar conditions. Directly comparable to NEMO Lab's Biorobotic Lab in applying assistive robotics to upper-limb mobility for neuromuscular patients.
• Penumbra (REAL Immersive System): Penumbra's REAL Immersive System is an FDA-cleared, VR-based rehabilitation platform for neurological and musculoskeletal patients in clinical and home settings. Directly comparable to NEMO Lab's Entertainment Lab and AIlay4Care VR rehabilitation module given shared focus on immersive VR therapy for neuromuscular rehabilitation.

Broad incumbents

• Sword Health: Digital musculoskeletal (MSK) care platform combining AI, sensor technology, and virtual physical therapy for MSK conditions. A broader incumbent in digital rehabilitation; while their focus is MSK rather than NMD, the business model (digital therapy platform + clinicians + wearable data) is structurally analogous to NEMO Lab's NIA telemonitoring and VR rehab approaches.

Emerging players

• CereProc: Provider of personalized synthetic voices (CereVoice) and voice banking services used to create custom AAC voices for patients at risk of speech loss. Directly comparable to NEMO Lab's Voice Lab voice/message banking service, both targeting preservation of personal vocal identity for AAC applications.
• Andiamo Health: Provides 3D-printed orthotics and prosthetics, particularly for pediatric neuromuscular patients. Direct peer to NEMO Lab's 3D Printing Lab and Ortho Lab in applying additive manufacturing to produce customized orthoses for neuromuscular indications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/nemolabofficial
• LinkedInlinkedin.com/company/nemolabofficial

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NEMO Lab